Cargando…

Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas

SIMPLE SUMMARY: T/NK-cell non-Hodgkin lymphomas (NHLs) represent approximately 10% of all NHLs and most patients have a poor outcome using current treatment options. Molecules involved in the host response against lymphoma cells are currently being investigated in an effort to develop novel therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xagoraris, Ioanna, Farrajota Neves da Silva, Pedro, Kokaraki, Georgia, Stathopoulou, Konstantina, Wahlin, Björn, Österborg, Anders, Herold, Nikolas, Ng, Siok-Bian, Medeiros, L. Jeffrey, Drakos, Elias, Sander, Birgitta, Rassidakis, George Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909177/ https://www.ncbi.nlm.nih.gov/pubmed/35267494 http://dx.doi.org/10.3390/cancers14051186

Ejemplares similares

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

P1304: THE NOVEL TUMOR SUPPRESSOR SAMHD1 CONTRIBUTES TO ANTI-TUMOR RESPONSES IN A CGAS-STING-DEPENDENT OR INDEPENDENT PATHWAY IN HODGKIN LYMPHOMA (HL)
por: Xagoraris, I., et al.
Publicado: (2022)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
por: Xagoraris, Ioanna, et al.
Publicado: (2022)

PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
por: Xagoraris, I., et al.
Publicado: (2022)

P1283: CIRCULATING IMMUNE CELLS IN CLASSICAL HODGKIN LYMPHOMA IN RELATION TO TUMOR BURDEN AND TREATMENT
por: Mulder, T. A., et al.
Publicado: (2022)

Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment
por: Mulder, Tom A., et al.
Publicado: (2022)

P032: Circulating immune biomarkers in classical Hodgkin lymphoma in relation to tumor burden and response to treatment.
por: Mulder, Tom A., et al.
Publicado: (2022)

Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
por: Rassidakis, George Z., et al.
Publicado: (2018)

Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
por: Merrien, Magali, et al.
Publicado: (2021)

Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders
por: Hue, Susan Swee-Shan, et al.
Publicado: (2022)

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

Interruption of p53-MDM2 Interaction by Nutlin-3a in Human Lymphoma Cell Models Initiates a Cell-Dependent Global Effect on Transcriptome and Proteome Level
por: Psatha, Konstantina, et al.
Publicado: (2023)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review
por: Saft, Leonie, et al.
Publicado: (2022)

Patterns in the Parathyroid Response to Sodium Bicarbonate Infusion Test in Healthy Volunteers
por: Papavramidis, Theodossis S., et al.
Publicado: (2014)

Natural killer (NK) activity in the spleen of patients with Hodgkin's disease and controls.
por: Al Sam, S., et al.
Publicado: (1982)

NK/T-cell non-Hodgkin lymphoma: Case report and review of the literature
por: Lungu, Mihaiela, et al.
Publicado: (2021)

ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
por: Ghaderi, Amineh, et al.
Publicado: (2020)

Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application
por: Mulder, Tom A., et al.
Publicado: (2019)

HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients
por: Zheng, Bingqing, et al.
Publicado: (2021)

STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models
por: Berger, Gilles, et al.
Publicado: (2022)

P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2022)

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)
por: Drakos, E, et al.
Publicado: (2011)

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells
por: Ghaderi, Amineh, et al.
Publicado: (2023)

Entinostat augments NK cell functions via epigenetic upregulation of IFIT1-STING-STAT4 pathway
por: Idso, John M., et al.
Publicado: (2020)

STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
por: Da, Yanyan, et al.
Publicado: (2022)

Gelsevirine is a novel STING-specific inhibitor and mitigates STING-related inflammation in sepsis
por: Chen, Yuhong, et al.
Publicado: (2023)

Rescue of Impaired NK Cell Activity in Hodgkin Lymphoma With Bispecific Antibodies In Vitro and in Patients
por: Reiners, Katrin S., et al.
Publicado: (2013)

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
por: Wästerlid, Tove, et al.
Publicado: (2021)

Sting /
por: Leduc, Jean-Marie
Publicado: (1992)

mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells
por: Chen, Weina, et al.
Publicado: (2010)

The transmittable through stinging microbiota differs between honeybees and wasps: a potentially greater microbial risk of the wasp sting for humans
por: Gkitsaki, Ioanna, et al.
Publicado: (2023)

Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
por: Georgila, Konstantina, et al.
Publicado: (2019)

Untargeted Ultrahigh-Performance Liquid Chromatography-Hybrid Quadrupole-Orbitrap Mass Spectrometry (UHPLC-HRMS) Metabolomics Reveals Propolis Markers of Greek and Chinese Origin
por: Stavropoulou, Maria-Ioanna, et al.
Publicado: (2021)

STING activation enhances cetuximab-mediated NK cell activation and DC maturation and correlates with HPV(+) status in head and neck cancer
por: Lu, Shanhong, et al.
Publicado: (2018)

Correction to: The transmittable through stinging microbiota differs between honeybees and wasps: a potentially greater microbial risk of the wasp sting for humans
por: Gkitsaki, Ioanna, et al.
Publicado: (2023)

The Evolving Knowledge on T and NK Cells in Classic Hodgkin Lymphoma: Insights into Novel Subsets Populating the Immune Microenvironment
por: Ferrarini, Isacco, et al.
Publicado: (2020)

The Buzz and the Sting
por: Bahabri, Sultan Abdullah
Publicado: (2002)

Hornet Sting
por: Finlayson, Walter J.
Publicado: (1908)

Insect Stings
Publicado: (1890)

Cannot write session to /tmp/vufind_sessions/sess_68rciqobr1p1j8a1jd83bcb4r4